Related Experiment Videos
Determinants of competitive antagonist sensitivity on neuronal nicotinic receptor beta subunits
1Department of Molecular and Cellular Pharmacology, University of Miami School of Medicine, Florida 33101, USA.
Abstract:
We constructed a series of chimeric and mutant neuronal nicotinic acetylcholine receptor beta subunits to map amino acid residues that determine sensitivity to competitive antagonists. The beta 2 and beta 4 subunits form pharmacologically distinct receptors when expressed in combination with the alpha 3 subunit in Xenopus oocytes. At equipotent acetylcholine concentrations, alpha 3 beta 2 is 56-fold more sensitive to blockage by dihydro-beta-erythroidine than is alpha 3 beta 4. The alpha 3 beta 2 combination is also sensitive to long-term blockade by neuronal bungarotoxin, whereas alpha 3 beta 4 is not. Pharmacological analysis of receptors formed by chimeric beta subunits reveals that amino acid residues that determine both dihydro-beta-erythroidine and neuronal bungarotoxin sensitivity are located within several sequence segments. The major determinant of sensitivity to both competitive antagonists is located between residues 54 and 63. A minor determinant of sensitivity to both antagonists lies between residues 1 and 54, whereas a minor determinant of NBT sensitivity lies between residues 74 and 80. Within region 54-63 of beta 2, mutant beta 2 subunits were used to identify threonine 59 as a residue critical in determining competitive antagonist sensitivity. Changing threonine 59 to lysine, as occurs in beta 4, causes a 9-fold decrease in dihydro-beta-erythroidine sensitivity and a 71-fold decrease in neuronal bungarotoxin sensitivity. Changing polar threonine 59 to negatively charged aspartate causes a 2.5-fold increase in neuronal bungarotoxin sensitivity and has no effect on dihydro-beta-erythroidine sensitivity.
Insights
Researchers identified key amino acid residues in neuronal nicotinic acetylcholine receptor beta subunits that control sensitivity to competitive antagonists like dihydro-beta-erythroidine and neuronal bungarotoxin.
Area of Science:
- Neuroscience
- Molecular Biology
- Pharmacology
Background:
- Neuronal nicotinic acetylcholine receptors (nAChRs) are crucial for neurotransmission.
- Pharmacological differences between nAChR subtypes, such as alpha 3 beta 2 and alpha 3 beta 4, are not fully understood.
- Understanding subunit interactions is key to characterizing receptor function.
Purpose of the Study:
- To map amino acid residues in beta subunits that dictate sensitivity to competitive antagonists.
- To elucidate the molecular basis for differential drug sensitivity between alpha 3 beta 2 and alpha 3 beta 4 nAChRs.
Main Methods:
- Construction and expression of chimeric and mutant neuronal nicotinic acetylcholine receptor beta subunits in Xenopus oocytes.
- Pharmacological characterization using acetylcholine, dihydro-beta-erythroidine, and neuronal bungarotoxin.
- Analysis of competitive antagonist sensitivity based on subunit composition and specific residue mutations.
Main Results:
- Alpha 3 beta 2 nAChRs are significantly more sensitive to dihydro-erythroidine and neuronal bungarotoxin than alpha 3 beta 4.
- Amino acid residues between positions 54-63 of the beta subunit are major determinants of sensitivity to both antagonists.
- Threonine 59 in the beta 2 subunit is critical, with mutations altering sensitivity to dihydro-erythroidine and neuronal bungarotoxin.
Conclusions:
- Specific amino acid residues within the beta subunit, particularly threonine 59, critically determine the sensitivity of nAChRs to competitive antagonists.
- These findings provide molecular insights into the differential pharmacology of nAChR subtypes.
- This research contributes to understanding nAChR function and the development of targeted therapeutics.